Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115784895B enables metal-free arylamine synthesis. Reduces cost and lead time for pharmaceutical intermediates manufacturing with high purity.
Patent CN116813544B reveals metal-free heating method for quinoline. Reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral induction method for Paxlovid intermediate. Reduces cost and improves safety. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN116023359A reveals a breakthrough copper-catalyzed amination route for aminothiophenes, offering superior yields and safety over traditional nitration for pharmaceutical supply chains.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand enabling high-yield nickel-catalyzed synthesis of chiral lactams for pharmaceutical intermediates.
Patent CN116199614B reveals high ee synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel patent CN107011218A enables high ee value synthesis of chiral amines reducing steps and improving supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110156710B details a novel Pd-catalyzed route for polysubstituted oxazoles. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN107936025B enables mild synthesis of chiral pyrazolidones. Eliminates heavy metals for cost reduction and supply chain reliability in pharmaceutical manufacturing.
Novel glucose-based route for trifluoromethyl triazoles. Mild conditions, scalable, cost-effective pharmaceutical intermediates manufacturing solution.
Patent CN110156710B details a scalable Pd-catalyzed route for polysubstituted oxazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109293491B details a metal-free photochemical acylation method. Offers high yields up to 72% for pharmaceutical intermediates without transition metals.
Patent CN118126005B details metal-free synthesis of dihydrobenzofuran compounds offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel synthesis of Remdesivir intermediates via CN113214320A offers high purity and scalable manufacturing. Discover cost-effective supply chain solutions for antiviral API production.
Patent CN115286556B reveals green synthesis for indolinone esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110724164B discloses novel 3-substituted spiro ligands achieving 99% ee. Enables cost-effective API intermediate manufacturing with high TON.
Novel 4-step process for high-purity intermediates. Reduces complexity and enhances supply chain reliability for global manufacturers.
Patent CN112812084B reveals a cost-effective iron phthalocyanine catalyzed route for benzofuran intermediates, offering significant supply chain and purity advantages.